{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-098546","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2025-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.836246+00:00","generated_at":"2026-05-17T04:06:07.359954+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"CEO Robert Lisicki takes medical leave; COO Kim Davis appointed interim CEO effective Oct 10","bullets":["CEO Robert Lisicki informed Zura Bio of a medical leave of absence starting October 10, 2025.","Board appointed Kim Davis (COO, CLO, Corporate Secretary) as interim CEO effective October 10, 2025.","Davis will serve as interim CEO in addition to her current duties as COO, CLO, and Corporate Secretary.","No arrangement, transactions under Item 404(a), or family relationships disclosed related to appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-098546","json":"https://secwatch.observer/filing/0001104659-25-098546.json","markdown":"https://secwatch.observer/filing/0001104659-25-098546.md","text":"https://secwatch.observer/filing/0001104659-25-098546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925098546/0001104659-25-098546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925098546/tm2528470d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:06:07.359954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}